Plus, news about Seres Therapeutics, Nestlé Health Science, Pfizer, Evotec and Relay Therapeutics:
FDA lifts partial hold on Stoke Therapeutics’ Dravet syndrome drug: The antisense oligonucleotide, zorevunersen, is now nearing Phase 3 development for the genetic disease. The FDA had placed higher doses of the drug on partial clinical
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Celebrating the bold leaders shaping the future through the world’s most ground-breaking companies WEST VALLEY, Utah, July 9, 2025 /PRNewswire/ — Ernst & Young LLP (EY US) today announced that John Lippert, Chief Technical Officer […]
SALT LAKE CITY, Nov. 12, 2024 /PRNewswire/ — USANA Health Sciences, Inc., a global leader in nutrition, was recently awarded Manufacturer of the Year for the third consecutive year by the Utah Manufacturers Association in […]
The agreement extends services to additional employers while continuing management of 17,000 members and 33 employer groups SALT LAKE CITY, Sept. 26, 2023 /PRNewswire/ — Select Health®, a nonprofit health plan serving more than 1 […]
Copyright © 2026 Biotech Networks
